DC Business DC

United Therapeutics advances new pulmonary hypertension treatment to FDA review

Washington Business Journal

Sep 11, 2019

United Therapeutics Corp. is a step closer to getting a new pulmonary arterial hypertension treatment to patients. The Silver Spring biotech's New Drug Application for Trevyent, a…

Read the full story at Washington Business Journal

United Therapeutics advances new pulmonary hypertension treatment to FDA review

More from DC Business

Shilling Canning files for bankruptcy protection amid rent struggles

Steve Case's Revolution teams with Hilton to deliver luxury Costa Rican resort 19 years in the making

Challenge to ACA preventive-care panel draws skepticism from Supreme Court

Can Trump remove Powell as Fed chair before his term ends?

Amazon closing one of its Northern Virginia supermarkets

International travelers give D.C.'s hospitality business only slight boost

Drone firm announces Virginia expansion and college partnership

Mixed-use development in downtown Bethesda looks to add more retail, residences